Theriva Biologics Q2 EPS $(0.07) Misses $(0.05) Estimate
Theriva Biologics (AMEX:TOVX) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.05) by 40 percent. This is a 96.37 percent increase over losses of $(1.93) per share from
Theriva lost more money per share than experts predicted, which shows the company is spending cash faster than expected. When a company misses on losses like this, it hints they might need more time or money to reach their goals.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.